No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. The unprecedented scope of the COVID-19 pandemic quickly gave rise to a surge of pledging activity, which is detailed in this article (see pp. Pandemic Pledges.
362 
Let's personalize your content